Lifecore Biomedical, Inc.
LFCR
$6.18
$0.030.49%
| Weiss Ratings | LFCR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | LFCR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Good | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | LFCR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.16 | |||
| Price History | LFCR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 3.52% | |||
| 30-Day Total Return | 0.65% | |||
| 60-Day Total Return | -13.51% | |||
| 90-Day Total Return | 14.66% | |||
| Year to Date Total Return | -7.21% | |||
| 1-Year Total Return | -21.47% | |||
| 2-Year Total Return | 16.38% | |||
| 3-Year Total Return | -48.20% | |||
| 5-Year Total Return | -34.26% | |||
| 52-Week High % Change | -24.91% | |||
| 52-Week Low % Change | 67.15% | |||
| Price | LFCR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $8.19 | |||
| 52-Week Low Price | $3.68 | |||
| 52-Week Low Price (Date) | Aug 29, 2024 | |||
| 52-Week High Price (Date) | Mar 08, 2024 | |||
| Valuation | LFCR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 227.71M | |||
| Enterprise Value | 393.90M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.59 | |||
| Earnings Per Share Growth | -76.05% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.61 | |||
| Price/Book (Q) | 14.72 | |||
| Enterprise Value/Revenue (TTM) | 3.01 | |||
| Price | $6.18 | |||
| Enterprise Value/EBITDA (TTM) | 2,697.96 | |||
| Enterprise Value/EBIT | -50.01 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | LFCR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 34.36M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | LFCR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | (952) 368-4300 | |||
| Address | 3515 Lyman Boulevard Chaska, MN 55318 | |||
| Website | www.lifecore.com | |||
| Country | United States | |||
| Year Founded | 1965 | |||
| Profitability | LFCR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -6.01% | |||
| Profit Margin | -10.89% | |||
| Management Effectiveness | LFCR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -1.96% | |||
| Return on Equity | -- | |||
| Income Statement | LFCR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 130.86M | |||
| Total Revenue (TTM) | 130.86M | |||
| Revenue Per Share | $3.81 | |||
| Gross Profit (TTM) | 45.64M | |||
| EBITDA (TTM) | 146.00K | |||
| EBIT (TTM) | -7.88M | |||
| Net Income (TTM) | -14.25M | |||
| Net Income Avl. to Common (TTM) | -14.25M | |||
| Total Revenue Growth (Q YOY) | 8.01% | |||
| Earnings Growth (Q YOY) | -146.14% | |||
| EPS Diluted (TTM) | -0.59 | |||
| EPS Diluted Growth (Q YOY) | -165.07% | |||
| Balance Sheet | LFCR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 9.46M | |||
| Cash Per Share (Q) | $0.28 | |||
| Total Current Assets (Q) | 81.86M | |||
| Total Preferred Equity (Q) | 44.31 | |||
| Total Equity (Q) | 59.76M | |||
| Current Ratio (Q) | 2.320 | |||
| Book Value Per Share (Q) | $0.42 | |||
| Total Assets (Q) | 255.39M | |||
| Total Current Liabilities (Q) | 35.29M | |||
| Total Debt (Q) | 131.34M | |||
| Total Liabilities (Q) | 195.63M | |||
| Total Common Equity (Q) | 15.45M | |||
| Cash Flow | LFCR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -14.75M | |||
| Cash from Financing (TTM) | 20.63M | |||
| Net Change in Cash (TTM) | 6.23M | |||
| Levered Free Cash Flow (TTM) | -22.13M | |||
| Cash from Operations (TTM) | 353.00K | |||
